Myopathy / rhabdomyolysis
Seek medical advice if unexplained muscle pain occurs.
Leaflet LIPOFIB 160mg capsules
- Product code:
- W43325002
- Quantity:
- 30
- Indicated for:
- dyslipidemia
- Route of administration:
- oral
- Substance:
- fenofibrate (fibrate lipid-lowering agent)
- ATC
- C10AB05 — Cardiovascular system | Lipid modifying agents | Lipid modifying agents, plain | Fibrates
Precautions:
Fenofibrate is an oral medication of the fibrate class used to treat abnormal blood lipid levels.
It is less commonly used compared than statins because it treats a different type of cholesterol abnormality to statins. While statins have strong evidence for reducing heart disease and death, there is evidence to suggest that fenofibrate also reduces the risk of heart disease and death. However, this seems only to apply to specific populations of people with elevated triglyceride levels and reduced high-density lipoprotein (HDL) cholesterol.
Its use is recommended together with dietary changes.
Common side effects include liver problems, breathing problems, abdominal pain, muscle problems, and nausea.
Serious side effects may include toxic epidermal necrolysis, rhabdomyolysis, gallstones, and pancreatitis.
Use during pregnancy and breastfeeding is not recommended.
It was patented in 1969, and came into medical use in 1975. It is available as a generic medication.
It is less commonly used compared than statins because it treats a different type of cholesterol abnormality to statins. While statins have strong evidence for reducing heart disease and death, there is evidence to suggest that fenofibrate also reduces the risk of heart disease and death. However, this seems only to apply to specific populations of people with elevated triglyceride levels and reduced high-density lipoprotein (HDL) cholesterol.
Its use is recommended together with dietary changes.
Common side effects include liver problems, breathing problems, abdominal pain, muscle problems, and nausea.
Serious side effects may include toxic epidermal necrolysis, rhabdomyolysis, gallstones, and pancreatitis.
Use during pregnancy and breastfeeding is not recommended.
It was patented in 1969, and came into medical use in 1975. It is available as a generic medication.
General data about LIPOFIB 160mg
- Substance:
- fenofibrate
- Date of latest medicines list:
- 01-06-2026
- Product code:
- W43325002
- Concentration:
- 160mg
- Pharmaceutical form:
- capsules
- Quantity:
- 30
- Product type:
- Generic medicine
- Price:
- 30.93 RON
- Prescription status:
- P-6L — Medicines dispensed with a medical prescription that is not retained by the pharmacy and may be renewed; the prescription may be used for 6 months from the date of issue.
Pharmaceutical forms available for fenofibrate
Concentrations available for fenofibrate
- 100mg
- 145mg
- 160mg
- 200mg
- 250mg
- 267mg
- 67mg
Combinations with other substances
Compensation lists for LIPOFIB 160mg Terapia
A - Sublist A with 90% discount from the reference price
- Price
- 30.93 RON
- Copayment
- 27.84 RON
- Patient
- 3.09 RON